COVID-19 大流行期间晚期肺癌诊断的挑战。
Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic.
机构信息
206608Nanjing Chest Hospital, Nanjing, China.
Affiliated Nanjing Brain Hospital, 56647Nanjing Medical University, Nanjing, China.
出版信息
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211050764. doi: 10.1177/15330338211050764.
A pandemic of coronavirus diseases 2019 (COVID-19) outbreak is a major public health emergency that has spread in the fastest speed, and caused the most extensive infection world widely. Transbronchial biopsy (TBB) and computed tomography guided percutaneous needle biopsy (CTPNB) is the most common and significant method for the diagnosis of lung cancer. During the COVID-19 pandemic, the indications of TBB and CTPNB must be managed strictly. Therefore, it is extremely indispensable to perform meticulous and individualized management for lung cancer patients to protect the patients from COVID-19.
2019 冠状病毒病（COVID-19）疫情大流行是一场重大的公共卫生紧急事件，其传播速度最快，造成了全球最广泛的感染。经支气管镜活检（TBB）和计算机断层扫描引导下经皮穿刺活检（CTPNB）是诊断肺癌最常见和最重要的方法。在 COVID-19 大流行期间，必须严格管理 TBB 和 CTPNB 的适应证。因此，对肺癌患者进行细致和个体化的管理以保护他们免受 COVID-19 的侵害是极其必要的。
Zotero 插件